These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10215957)

  • 21. Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation.
    Herzog RW; Mount JD; Arruda VR; High KA; Lothrop CD
    Mol Ther; 2001 Sep; 4(3):192-200. PubMed ID: 11545609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial deletion by illegitimate recombination of the factor IX gene in a haemophilia B family with two inhibitor patients.
    Green PM; Bentley DR; Mibashan RS; Giannelli F
    Mol Biol Med; 1988 Apr; 5(2):95-106. PubMed ID: 3398774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of mutations in the F9 gene including exon deletion by multiplex ligation-dependent probe amplification in 33 unrelated Korean patients with haemophilia B.
    Kwon MJ; Yoo KY; Kim HJ; Kim SH
    Haemophilia; 2008 Sep; 14(5):1069-75. PubMed ID: 18624698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A haemophilia B patient with severe burn injury: increased requirement for factor IX replacement therapy associated with venous thromboembolism.
    Yaish H; Rodgers GM
    Haemophilia; 2008 May; 14(3):607-9. PubMed ID: 18194306
    [No Abstract]   [Full Text] [Related]  

  • 26. Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.
    Barnes C; Davis A; Furmedge J; Egan B; Donnan L; Monagle P
    Haemophilia; 2010 Sep; 16(5):840-1. PubMed ID: 20546030
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect.
    Jenkins PV; Egan H; Keenan C; O'Shea E; Smith OP; Nolan B; White B; O'Donnell J
    Haemophilia; 2008 Jul; 14(4):717-22. PubMed ID: 18479429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice.
    Zhang TP; Jin DY; Wardrop RM; Gui T; Maile R; Frelinger JA; Stafford DW; Monahan PE
    Gene Ther; 2007 Mar; 14(5):429-40. PubMed ID: 17066096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemophilia B caused by a missense mutation in the prepeptide sequence of factor IX.
    Green PM; Mitchell VE; McGraw A; Goldman E; Giannelli F
    Hum Mutat; 1993; 2(2):103-7. PubMed ID: 8318985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor IX inhibitors and anaphylaxis in hemophilia B.
    Warrier I; Ewenstein BM; Koerper MA; Shapiro A; Key N; DiMichele D; Miller RT; Pasi J; Rivard GE; Sommer SS; Katz J; Bergmann F; Ljung R; Petrini P; Lusher JM
    J Pediatr Hematol Oncol; 1997; 19(1):23-7. PubMed ID: 9065715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors in young boys with haemophilia.
    Lusher JM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gene diagnosis of 3 haemophilia B families].
    Zhang Y; Yang LH; Lu YL; Ding QL; Wang XF; Liu XE; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):179-82. PubMed ID: 18788618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.
    Boekhorst J; Lari GR; D'Oiron R; Costa JM; Nováková IR; Ala FA; Lavergne JM; VAN Heerde WL
    Haemophilia; 2008 Jul; 14(4):729-35. PubMed ID: 18503540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achievement of immune tolerance in a patient with haemophilia B and inhibitory antibodies, complicated by an anaphylactoid reaction.
    Curry NS; Misbah SA; Giangrande PL; Keeling DM
    Haemophilia; 2007 May; 13(3):328-30. PubMed ID: 17498084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.
    Najaf SM; Malik A; Quraishi AU; Kazmi K; Kakepoto GN
    Ann Hematol; 2004 Sep; 83(9):604-7. PubMed ID: 15205916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.
    Kay MA; Manno CS; Ragni MV; Larson PJ; Couto LB; McClelland A; Glader B; Chew AJ; Tai SJ; Herzog RW; Arruda V; Johnson F; Scallan C; Skarsgard E; Flake AW; High KA
    Nat Genet; 2000 Mar; 24(3):257-61. PubMed ID: 10700178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
    Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
    Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.